The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT
2023年欧洲骨髓移植协会（EBMT）关于造血细胞移植和细胞疗法的报告指出，异基因造血干细胞移植（HCT）在髓系恶性肿瘤治疗中的应用日益增多，CAR-T疗法的使用也随之增加，而自体造血干细胞移植的使用则相应减少。
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-025-02524-2
Passweg, Jakob R; Baldomero, Helen; Atlija, Marina; Kleovoulou, Iliana; Witaszek, Aleksandra; Alexander, Tobias; Angelucci, Emanuele; Averbuch, Dina; Bazarbachi, Ali; Ciceri, Fabio; Greco, Raffaella; Hazenberg, Mette D; Kalwak, Krzysztof; McLornan, Donal P; Neven, Bénédicte; Perić, Zinaida; Risitano, Antonio M; Ruggeri, Annalisa; Sánchez-Ortega, Isabel; Snowden, John A; Sureda, Anna
